Filed: 5/14/2024ACC: 0001104659-24-060699
📋 What this filing means
CATALYS PACIFIC, LLC filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $148.14M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$148.14M
Total AUM (reported)
11.23M
Total Shares
Allocation by class
COM$148.14M100.0%
Portfolio Concentration
Top 3$148.14M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 11.23M
Sole
Full voting authority
11.23M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
Mineralys Therapeutics, Inc.
SOLEShares9.19M
TypeSH
Market value$118.70M
80.13%
Sole
9.19M
Shared
0.00
None
0.00
HilleVax , Inc.
SOLEShares1.31M
TypeSH
Market value$21.77M
14.69%
Sole
1.31M
Shared
0.00
None
0.00
Phathom Pharmaceuticals, Inc.
SOLEShares721.96K
TypeSH
Market value$7.67M
5.18%
Sole
721.96K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Mineralys Therapeutics, Inc.SOLE | COM | 9.19M | SH | $118.70M 80.13% | 9.19M | 0.00 | 0.00 |
HilleVax , Inc.SOLE | COM | 1.31M | SH | $21.77M 14.69% | 1.31M | 0.00 | 0.00 |
Phathom Pharmaceuticals, Inc.SOLE | COM | 721.96K | SH | $7.67M 5.18% | 721.96K | 0.00 | 0.00 |